report by BlackRock
Results for ""
Market Outlooks
The value of small caps for the road ahead
This piece is approved to use with clients.
Portfolio Managers Justin Tugman and Craig Kempler explain how the current state of small caps and a defensive value approach complement the market environment they expect in the coming years.
Market Outlooks
Taking the Long View on Market Volatility: A Global Equities Conversation
This piece is approved to use with clients.
Structural shifts in the global economy and market dynamics continue to drive volatility in equities: what should smart investors be doing right now?
Market Outlooks
Revisiting U.S. Growth in a Challenging Environment
This piece is approved to use with clients.
Portfolio Managers Doug Rao and Brian Demain discuss the changing market environment for growth equities ‒ from the Russia/Ukraine conflict to repercussions developing from the COVID policy response.
Market Outlooks
2021 – In a Word: Recovery
This piece is approved to use with clients.
Andrew Mulliner, Portfolio Manager and Head of Global Aggregate Strategies, explains why 2021 will likely be a year of recovery, though he cautions that investors should keep one eye on inflation and inflation expectations.
Market Outlooks
AAM Viewpoints: A dive into 2020 Fixed Income Markets & what they tell us for 2021
This piece is approved to use with clients.
The unfolding of diverse and largely unseen set of events in 2020 make it difficult to select only a few that we feel represent the tenor of the fixed income markets and the broad economy within this commentary. Clearly, the migration back into risk assets beginning in Q2 (the 2nd quarter) continued through Q4 2020 buttressed by what we think can be four primary causes:
Market Outlooks
AAM Viewpoints: Let’s party like it’s 1999!
This piece is approved to use with clients.
As the calendar changed from 2020 to 2021, I can’t help but find an environment that is truly surreal. We have a raging global pandemic on our hands that is getting markedly worse on a day-by-day basis, we have vaccines that are sitting in warehouses being administered at one-tenth the rate that is necessary to accomplish the task at hand and we have millions without a job with difficult prospects of getting one in the near future.
Market Outlooks
AAM Viewpoints: Equity market side effects of the covid-19 vaccine
This piece is approved to use with clients.
The 337 days spanning the World Health Organization’s announcement of COVID-19 to the FDA approval of the first vaccine the world witnessed many social, economic, and scientific events few thought possible.